Cover Image
Market Research Report
Product code 
916577

Nutrigenomics Market by Application and Geography - Forecast and Analysis 2020-2024

Published: | TechNavio (Infiniti Research Ltd.) | 139 Pages | Delivery time: 1-2 business days

Price

Back to Top
Nutrigenomics Market by Application and Geography - Forecast and Analysis 2020-2024
Published: October 26, 2019
TechNavio (Infiniti Research Ltd.)
Content info: 139 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

About this market

Technavio's nutrigenomics market analysis considers sales from obesity, cardiovascular diseases, and cancer research applications. Our study also finds the sales of nutrigenomics in Asia, Europe, North America, and ROW. In 2019, the obesity segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing number of obese people will play a significant role in the obesity segment to maintain its market position. Also, our global nutrigenomics market report looks at factors such as increasing cost of medical treatment, growing investments by government and private stakeholders, and rising number of health-conscious people. However, high cost and unavailability of user-friendly tools for easy interpretation of data, low awareness of nutrigenomic technologies in emerging economies, and lack of skilled professionals may hamper the growth of the nutrigenomics industry over the forecast period.

Overview

The increasing cost of medical treatment

There is an increase in the overall healthcare costs due to the rising prevalence of disease and increasing expenditure on hospitals, medicine, and treatment. The medical expenditure by patients is also increasing because branded drugs are expensive. This is driving them to consume fortified dairy products and dietary supplements to prevent health issues and stay healthy. Fortified dairy and dietary supplements contain nutrients such as polyphenols, carotenoids, and vitamins that are based on nutrigenomics. Thus, this will boost the dependence on nutrigenomics, which will lead to the expansion of the global nutrigenomics market at a CAGR of over 11% during the forecast period.

Increasing prevalence of obesity

The increase in rich, fatty, and high-calorie food and the decrease in physical activities have led to the increasing incidence of obesity worldwide. With the growing rate of obesity, the burden on public health is increased, leading to more patients opting for nutrigenetic testing to aid in obesity management. Obesity can lead to several diseases, including high blood pressure, diabetes, gallbladder disease, sleep apnea, kidney disease, cancer, osteoarthritis, cardiac disease, and breathing problems. Nutrigenomics help in identifying the nutrients and gene interaction and in achieving long-term weight loss in a sustainable way. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global nutrigenomics market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of a few major players, the global nutrigenomics market is concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading nutrigenomics manufacturers, that include BASF SE, Cell-Logic, Danone, DSM, Genova Diagnostics Inc., GX Sciences Inc., Metagenics Inc., Nutrigenomix Inc., Unilever Group, and Xcode Life Sciences Private Limited.

Also, the nutrigenomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Product Code: IRTNTR40037

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value Chain Analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market Outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

  • Market segmentation by application
  • Comparison by application
  • Obesity - Market size and forecast 2019-2024
  • Cardiovascular diseases - Market size and forecast 2019-2024
  • Cancer research - Market size and forecast 2019-2024
  • Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Rising demand for training in and awareness of nutrigenomics technologies
  • Increasing approval of grants
  • Increasing prevalence of obesity

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • BASF SE
  • Cell-Logic
  • Danone
  • DSM
  • Genova Diagnostics Inc.
  • GX Sciences Inc.
  • Metagenics Inc.
  • Nutrigenomix Inc.
  • Unilever Group
  • Xcode Life Sciences Private Limited

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendor offerings
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Application - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by application
  • Exhibit 20: Obesity - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Obesity - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Cardiovascular diseases - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Cardiovascular diseases - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Cancer research - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 25: Cancer research - Year-over-year growth 2020-2024 (%)
  • Exhibit 26: Market opportunity by application
  • Exhibit 27: Customer landscape
  • Exhibit 28: Market share by geography 2019-2024 (%)
  • Exhibit 29: Geographic comparison
  • Exhibit 30: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 37: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 38: Key leading countries
  • Exhibit 39: Market opportunity
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: BASF SE - Vendor overview
  • Exhibit 47: BASF SE - Business segments
  • Exhibit 48: BASF SE - Organizational developments
  • Exhibit 49: BASF SE - Geographic focus
  • Exhibit 50: BASF SE - Segment focus
  • Exhibit 51: BASF SE - Key offerings
  • Exhibit 52: Cell-Logic - Vendor overview
  • Exhibit 53: Cell-Logic - Product segments
  • Exhibit 54: Cell-Logic - Key offerings
  • Exhibit 55: Danone - Vendor overview
  • Exhibit 56: Danone - Business segments
  • Exhibit 57: Danone - Organizational developments
  • Exhibit 58: Danone - Geographic focus
  • Exhibit 59: Danone - Segment focus
  • Exhibit 60: Danone - Key offerings
  • Exhibit 61: DSM - Vendor overview
  • Exhibit 62: DSM - Business segments
  • Exhibit 63: DSM - Organizational developments
  • Exhibit 64: DSM - Segment focus
  • Exhibit 65: DSM - Key offerings
  • Exhibit 66: Genova Diagnostics Inc. - Vendor overview
  • Exhibit 67: Genova Diagnostics Inc. - Product segments
  • Exhibit 68: Genova Diagnostics Inc. - Organizational developments
  • Exhibit 69: Genova Diagnostics Inc. - Key offerings
  • Exhibit 70: GX Sciences Inc. - Vendor overview
  • Exhibit 71: GX Sciences Inc. - Product segments
  • Exhibit 72: GX Sciences Inc. - Organizational developments
  • Exhibit 73: GX Sciences Inc. - Key offerings
  • Exhibit 74: Metagenics Inc. - Vendor overview
  • Exhibit 75: Metagenics Inc. - Product segments
  • Exhibit 76: Metagenics Inc. - Key offerings
  • Exhibit 77: Nutrigenomix Inc. - Vendor overview
  • Exhibit 78: Nutrigenomix Inc. - Product segments
  • Exhibit 79: Nutrigenomix Inc. - Key offerings
  • Exhibit 80: Unilever Group - Vendor overview
  • Exhibit 81: Unilever Group - Business segments
  • Exhibit 82: Unilever Group - Organizational developments
  • Exhibit 83: Unilever Group - Geographic focus
  • Exhibit 84: Unilever Group - Segment focus
  • Exhibit 85: Unilever Group - Key offerings
  • Exhibit 86: Xcode Life Sciences Private Limited - Vendor overview
  • Exhibit 87: Xcode Life Sciences Private Limited - Product segments
  • Exhibit 88: Xcode Life Sciences Private Limited - Key offerings
  • Exhibit 89: Validation techniques employed for market sizing
  • Exhibit 90: Definition of market positioning of vendors